Olopatadine hydrochloride is an antihistamine drug that relieves the symptoms of seasonal and perennial allergic rhinitis (hay fever and other allergies) by blocking histamine that causes sneezing, itchiness, and tears. It is currently available as ophthalmic solutions and intranasal sprays.
Olopatadine hydrochloride is used to treat allergic rhinitis and allergic eye symptoms such as itching, redness, tearing, and burning. It is also used to treat allergic skin reactions.
Olopatadine hydrochloride is an antihistamine which works by blocking the action of histamine. By blocking the activity of histamine, it reduces the symptoms of allergies such as sneezing, itching, watery eyes, and congestion.
Olopatadine hydrochloride typically takes several hours to take effect, and its full effects may not be felt for up to 24 hours.
Olopatadine hydrochloride is rapidly and nearly completely absorbed from the eye through the mucous membranes.
Olopatadine hydrochloride is eliminated primarily through metabolism in the liver, and only a small amount is excreted unchanged in the urine.
The recommended adult dosage for olopatadine hydrochloride is one or two drops of either 0.2% Olodin DS Ophthalmic Solution 0.2% ophthalmic solution or 0.6% Olodin DS Ophthalmic Solution 0.2% ophthalmic solution applied to the affected eye(s) once or twice daily.
For intranasal use, the recommended dose for adults is one or two sprays of either 0.1% or 0.6% olopatadine hydrochloride intranasal spray per nostril once or twice daily.
Olopatadine hydrochloride is typically administered to the eye(s) or intranasally. It should not be administered intravenously or orally.
The most common side effects of olopatadine hydrochloride include redness, stinging, burning, itching, eye pain, increased tear production, and blurred vision.
There is no information available on the toxicity of olopatadine hydrochloride.
Patients should inform their doctor if they are pregnant, breastfeeding, or have any other medical conditions. Olopatadine hydrochloride should not be used by patients with glaucoma or any other eye conditions, or in patients taking monoamine oxidase inhibitors.
Olopatadine hydrochloride may interact with certain medications. Patients should inform their doctor if they are taking other medications before using olopatadine hydrochloride.
Olopatadine hydrochloride may interact with certain medical conditions. Patients should inform their doctor if they have any medical conditions before using olopatadine hydrochloride.
Olopatadine hydrochloride may interact with certain drugs. Patients should inform their doctor if they are taking any other drugs before using olopatadine hydrochloride.
Food interactions have not been established.
Olopatadine hydrochloride should not be used by pregnant women.
Olopatadine hydrochloride should not be used while breastfeeding.
An acute overdose of olopatadine hydrochloride is unlikely to occur, since olopatadine hydrochloride is poorly absorbed when taken orally.
Olopatadine hydrochloride is contraindicated in patients with glaucoma, any other eye conditions, or in patients taking monoamine oxidase inhibitors.
The recommended adult dosage for olopatadine hydrochloride is one or two drops of either 0.2% Olodin DS Ophthalmic Solution 0.2% ophthalmic solution or 0.6% Olodin DS Ophthalmic Solution 0.2% ophthalmic solution applied to the affected eye(s) once or twice daily. For intranasal use, the recommended dose for adults is one or two sprays of either 0.1% or 0.6% olopatadine hydrochloride intranasal spray per nostril once or twice daily.
Store olopatadine hydrochloride in a cool, dry place away from direct light.
The volume of distribution of olopatadine hydrochloride is not known.
The half-life of olopatadine hydrochloride is not known.
Olopatadine hydrochloride is cleared from the body primarily through metabolism in the liver.
See in details version Olodin DS Ophthalmic Solution 0.2% also Olodin DS Ophthalmic Solution 0.2% in bangla